United States
I am an immunology and biomarker scientist with over 4.5 years of experience supporting clinical programs through cellular and humoral immune response analysis, flow cytometry data processing and visualization, and interpretation of T cell and other immune cell phenotypes. I work at the interface of research, clinical development, and regulatory teams to translate complex immunology data into clear, clinically relevant insights. My background includes managing immunologic and biomarker assay work with external vendors, overseeing timelines, and reviewing assay deliverables to ensure data integrity and alignment with expected biological outcomes. I also evaluate new vendors and workflows for upcoming studies and clinical programs. In addition, I contribute to scientific communications by preparing publication-quality figures, data summaries, and supporting abstracts and manuscripts, as well as presenting immunology data in cross-functional settings.
Providing scientific content support for a late‑stage clinical program, including figure development, manuscript contributions, and data interpretation for clinical deliverables
• Analyzed cellular and humoral immune responses in Phase 1-3 clinical studies, including processing and visualizing flow cytometry data to characterize T cell and other immune cell phenotypes. • Reviewed immunology and biomarker data from external vendors, evaluating deliverables for sample quality and data integrity. • Partnered with CROs and assay vendors to manage timelines, deliverables, and troubleshooting for ongoing and upcoming clinical trials. • Assessed new vendors, assay platforms, and workflows to support planning for future studies and clinical programs. • Interpreted immunology data for internal discussions, preparing figures, summaries, and slide decks for cross-functional meetings. • Prepared analyses and publication-quality figures for internal presentations and scientific manuscripts, including slide decks summarizing immunologic mechanisms, biomarker data, and disease-area insights. • Collaborated with research, clinical development, and regulatory-adjacent teams to contextualize immunology data and support program needs. • Participated in monthly cross-functional update meetings, observing discussions on trial logistics, operational progress, and site-level considerations.
• Supported immunology analyses of clinical trials by working at the interface of research, clinical, and regulatory teams. • Performed gating an analysis of multiparametric flow cytometry data and contributed to interpretation and visualization of cellular and humoral immune responses. • Generated clear, publication-quality figures for internal presentations and supported writing for abstracts, manuscripts, and internal reports. • Collaborated with external vendors on immunologic and biomarker assays, reviewing data and coordinating assay-related questions. • Stayed current on emerging immunology research to inform ongoing clinical programs and internal scientific discussions.
• Analyzed the role of DNA Polymerase ϴ (POLϴ) in leukemogenesis, and evaluated POLϴ as a therapeutic target in acute myeloid leukemia. • Mentored undergraduates, rotating graduate students, and rotating medical students in advanced laboratory techniques such as flow cytometry, mammalian cell culture, plasmid DNA transfections, western blotting, PCR, and electrophoresis. • Trained incoming postdoctoral fellows and graduate students to isolate murine bone marrow and peripheral blood, stain cells with up to four colors for subsequent immunophenotyping, independently operate BD FACSCanto II, and analyze data using FACSDiva and FlowJo software. • Cohosted the 2019 annual Fels Institute for Cancer Trainee Day (May 24, 2019), which involved presenting the speakers, helping to select the speakers and poster presentations, and encouraging participation of graduate students and postdoctoral fellows
• Research focused on specific the targeting of BRCA-deficient cancers via the concept of Synthetic Lethality. • Performed in vitro screens for small molecule inhibitors, tests inhibitors in BRCA-deficient cell lines and primary patient cells • Maintained and bred transgenic mouse colonies, and isolates/immunophenotypes mouse bone marrow, peripheral blood, and spleen cells via flow cytometry. • Mentored multiple undergraduates and rotating graduate students in cell culture and DNA subcloning techniques. • Oversaw key laboratory infrastructure, including campus-wide irradiator access and training, and management of the chemical and reagent inventory through the CEMS tracking system.
• Studied the protein FANCJ, a helicase that is associated with Fanconi's Anemia and a genetic pre-disposition to breast cancer. • Performed plasmid mini-preps, restriction digests, agarose & polyacrylamide gel electrophoresis, ligations, transformations, PCR site-directed mutagenesis, and designed primers for site-directed mutagenesis.